Retrospective Cohort Study on Asian Patients with Hidradenitis Suppurativa: Factors Associated with the Efficacy of Antibiotic Treatment


  • Yun Kyung Jang Department of Dermatology, CHA Bundang Medical Center,
  • Sujin Moon
  • Jung U Shin
  • Dong Hyun Kim
  • Hee Jung Lee Department of Dermatology, CHA Bundang Medical Center, CHA University, Seongnam 13496, Korea



clindamycin, hidradenitis suppurativa, tetracycline, treatment response


Abstract is missing (Short communication)


Download data is not yet available.


Saunte DML, Jemec GBE. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA 2017; 318: 2019-2032. DOI:

Lee JH, Kwon HS, Jung HM, Kim GM, Bae JM. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol 2018; 32: 1784-1790. DOI:

Omine T, Miyagi T, Hayashi K, Yamaguchi S, Takahashi K. Clinical characteristics of hidradenitis suppurativa patients in Okinawa, Japan: differences between East Asia and Western countries. J Dermatol 2020; 47: 855-862. DOI:

Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2020; 82: 1045-1058. DOI:

Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, et al; European Hidradenitis Suppurativa Foundation Investigator Group. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017; 177: 1401-1409. DOI:

Caposiena Caro RD, Cannizzaro MV, Botti E, Di Raimondo C, Di Matteo E, Gaziano R, et al. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasound observations. J Am Acad Dermatol 2019; 80: 1314-1321. DOI:

Rosi E, Pescitelli L, Ricceri F, Di Cesare A, Novelli A, Pimpinelli N, et al. Clindamycin as unique antibiotic choice in hidradenitis suppurativa. Dermatol Ther 2019; 32: e12792. DOI:

Delaunay J, Villani AP, Guillem P, Tristan A, Boibieux A, Jullien D. Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients. Br J Dermatol 2018; 178: e15-e16. DOI:

Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, et al. Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol 2022; 86: 1092-1101. DOI:

Denny G, Anadkat MJ. The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: an institutional retrospective cohort study. J Am Acad Dermatol 2017; 76: 54-59. DOI:

Iannone M, Janowska A, Bartolomei G, Puntoni M, Oranges T, Romanelli M, et al. Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy. Dermatol Ther 2021; 34: e14919. DOI:

Pan WH, Yeh WT. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr 2008; 17: 370-374.

Martorell A, Jfri A, Koster SBL, Gomez-Palencia P, Solera M, Alfaro-Rubio A, et al. Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study. J Eur Acad Dermatol Venereol 2020; 34: 1309-1318. DOI:

van der Zee HH, Jemec GB. New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes. J Am Acad Dermatol 2015; 73: S23-S26. DOI:

Additional Files



How to Cite

Jang, Y. K., Moon, S., Shin, J. U., Kim, D. H. ., & Lee, H. J. . (2022). Retrospective Cohort Study on Asian Patients with Hidradenitis Suppurativa: Factors Associated with the Efficacy of Antibiotic Treatment. Acta Dermato-Venereologica, 102, adv00797.



Short Communication